Understanding communication about immunotherapy between patients and providers
Official title: Communication Issues in Patient/Provider Discussions of Immunotherapy
Run by Emory University · NCT05873608 · Data updated 2026-11-12
This study looks at how well patients and doctors talk about immunotherapy to see if better communication can help patients understand their treatment options.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 125 (estimated) |
| Sponsor | Emory University Academic / other |
| Drugs / interventions | immunotherapy |
| Locations | 2 sites (Atlanta, Georgia and 1 other locations) |
| Status | Recruiting |
| Started | October 6, 2016 |
| Main results expected | September 17, 2027 |
| Study ends | November 17, 2027 |
| Registry record updated | April 6, 2026 |
| Trial ID | NCT05873608 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients and providers who are involved in discussions about immunotherapy at the Winship Cancer Institute.
✕Probably not a fit
Patients who are not engaged in discussions about immunotherapy or those not receiving cancer treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates communication issues in discussions about immunotherapy between patients and healthcare providers. It aims to identify misunderstandings regarding the risks and benefits of immunotherapy, assess patient comprehension of technical terms, and explore preferences for information sharing. The study involves observing patient-provider conversations, conducting interviews, and testing the effectiveness of educational videos designed to enhance understanding of immunotherapy. The ultimate goal is to improve patient knowledge and decision-making regarding immunotherapy treatments.
Why it matters
Potential benefit: If successful, this study could enhance patient understanding of immunotherapy, leading to better-informed treatment decisions.
How similar studies have gone: While communication issues in healthcare have been studied, this specific approach focusing on immunotherapy discussions is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * AIMS 1-3: All patients and providers who may have a discussion about immunotherapy at the Winship Cancer Institute * AIM 4: Any cancer patient
Where it's running
-
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, United States Recruiting -
Atlanta VA Medical Center
Decatur, Georgia, United States Recruiting
Study contacts
- Principal investigator: Rebecca Pentz, PhD — Emory University Hospital/Winship Cancer Institute
- Study coordinator: Rebecca Pentz, PhD
- Email: rpentz@emory.edu
- Phone: 404-778-5694
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual reality to reduce psychological symptom burden during cancer treatment
This trial will try virtual reality sessions to reduce anxiety, depression, and adjustment symptoms for adults receiving cancer treatment.
-
Connecting underrepresented populations to clinical trials at Ohio State University
This study is trying to find better ways to connect racial and ethnic minorities to cancer clinical trials at Ohio State University to help them participate more.
-
Virtual group therapy to improve psychological wellbeing in cancer patients
This study is testing if virtual group therapy that combines acceptance and commitment therapy with compassion can help improve the mental wellbeing of cancer patients.
-
Community-based exercise program for cancer survivors
This study tests a 12-week exercise program for cancer survivors to see if it helps them feel better and improves their quality of life.
-
New blood and urine tests for cancer screening
This study is testing new blood and urine tests for cancer screening to see how well they work in people without known cancer and how different health factors might affect the results.
-
Telemedicine support for older cancer patients in underserved communities
This study tests whether using telemedicine to provide extra support can help older cancer patients in underserved communities feel better and have fewer hospital visits compared to standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.